|Publication number||US20050033310 A1|
|Application number||US 10/848,571|
|Publication date||Feb 10, 2005|
|Filing date||May 17, 2004|
|Priority date||Sep 11, 2001|
|Also published as||CA2459702A1, CA2459702C, DE60230638D1, EP1424970A2, EP1424970A4, EP1424970B1, EP2078502A2, EP2078502A3, US7757692, US8414655, US8974484, US20030050648, US20040206349, US20040211412, US20040243140, US20090205667, US20110054632, US20130345737, WO2003022124A2, WO2003022124A3|
|Publication number||10848571, 848571, US 2005/0033310 A1, US 2005/033310 A1, US 20050033310 A1, US 20050033310A1, US 2005033310 A1, US 2005033310A1, US-A1-20050033310, US-A1-2005033310, US2005/0033310A1, US2005/033310A1, US20050033310 A1, US20050033310A1, US2005033310 A1, US2005033310A1|
|Inventors||Clifton Alferness, Richard Lin, Wilfred Jaeger|
|Original Assignee||Alferness Clifton A., Lin Richard Y., Jaeger Wilfred E.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (99), Referenced by (31), Classifications (20), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This is a continuation of U.S. patent application Ser. No. 09/951,105, filed on Sep. 11, 2001, the entire contents of which are incorporated herein by reference.
The present invention is generally directed to a treatment of Chronic Obstructive Pulmonary Disease (COPD). The present invention is more particularly directed to removable air passageway obstruction devices, and systems and methods for removing the devices.
Chronic Obstructive Pulmonary Disease (COPD) has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.
The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991 COPD was the fourth leading cause of death in the United States and had increased 33% since 1979.
COPD affects the patients whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking up hill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time.
COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.
Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled .beta.-agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the procedure was abandoned.
The lung volume reduction surgery (LVRS) was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor due to the fact that Medicare stopping reimbursing for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. What data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life. However, the surgery is not without potential complications. Lung tissue is very thin and fragile. Hence, it is difficult to suture after sectioning. This gives rise to potential infection and air leaks. In fact, nearly thirty percent (30%) of such surgeries result in air leaks.
Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory muscaulature, and improved right ventricular filling.
Lastly, lung transplantation is also an option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients.
In view of the need in the art for new and improved therapies for COPD which provide more permanent results than pharmacotherapy while being less invasive and traumatic than LVRS, at least two new therapies have recently been proposed.
Both of these new therapies provide lung size reduction by permanently collapsing at least a portion of a lung.
In accordance with a first one of these therapies, and as described in U.S. Pat. No. 6,258,100 assigned to the assignee of the present invention and incorporated herein by reference, a lung may be collapsed by obstructing an air passageway communicating with the lung portion to be collapsed. The air passageway may be obstructed by placing an obstructing member in the air passageway. The obstructing member may be a plug-like device which precludes air flow in both directions or a one-way valve which permits air to be exhaled from the lung portion to be collapsed while precluding air from being inhaled into the lung portion. Once the air passageway is sealed, the residual air within the lung will be absorbed over time to cause the lung portion to collapse.
As further described in U.S. Pat. No. 6,258,100, the lung portion may be collapsed by inserting a conduit into the air passageway communicating with the lung portion to be collapsed. An obstruction device, such as a one-way valve is then advanced down the conduit into the air passageway. The obstruction device is then deployed in the air passageway for sealing the air passageway and causing the lung portion to be collapsed.
The second therapy is fully described in copending U.S. application Ser. No. 09/534,244, filed Mar. 23, 2000, for LUNG CONSTRICTION APPARATUS AND METHOD and, is also assigned to the assignee of the present invention. As described therein, a lung constriction device including a sleeve of elastic material is configured to cover at least a portion of a lung. The sleeve has a pair of opened ends to permit the lung portion to be drawn into the sleeve. Once drawn therein, the lung portion is constricted by the sleeve to reduce the size of the lung portion.
Both therapies hold great promise for treating COPD. Neither therapy requires sectioning and suturing of lung tissue.
While either therapy alone would be effective in providing lung size reduction and treatment of COPD, it has recently been proposed that the therapies may be combined for more effective treatment. More specifically, it has been proposed that the therapies could be administered in series, with the first mentioned therapy first applied acutely for evaluation of the effectiveness of lung size reduction in a patient and which lung portions should be reduced in size to obtain the best results. The first therapy is ideal for this as it is noninvasive and could be administered in a physician's office. Once the effectiveness of lung size reduction is confirmed and the identity of the lung portions to be collapsed is determined, the more invasive second mentioned therapy may be administered.
In order to combine these therapies, or simply administer the first therapy for evaluation, it will be necessary for at least some of the deployed air passageway obstruction devices to be removable. Unfortunately, such devices as currently known in the art are not suited for removal. While such devices are expandable for permanent deployment, such devices are not configured or adapted for recollapse after having once been deployed in an air passageway to facilitate removal. Hence, there is a need in the art for air passageway obstruction devices which are removable after having been deployed and systems and methods for removing them.
The invention provides device for reducing the size of a lung comprising an obstructing structure dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the obstructing structure having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung, the obstructing structure being collapsible to permit removal of the obstruction device from the air passageway.
The invention further provides an assembly comprising a device for reducing the size of a lung, the device being dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the device having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung, a catheter having an internal lumen and being configured to be passed down a trachea, into the air passageway, and a retractor dimensioned to be passed down the internal lumen of the catheter, seizing the device, and pulling the obstruction device proximally into the internal lumen to remove the device from the air passageway. The device is collapsible after having been deployed to permit the device to be pulled proximally into the internal lumen of the catheter by the retractor.
The invention further provides a method of removing a deployed air passageway obstruction device from an air passageway in which the device is deployed. The method includes the steps of passing a catheter, having an internal lumen, down a trachea and into the air passageway, advancing a retractor down the internal lumen of the catheter to the device, seizing the device with the retractor, collapsing the device to free the device from deployment in the air passageway, and pulling the device with the retractor proximally into the internal lumen of the catheter.
The invention still further provides an air passageway obstruction device comprising a frame structure, and a flexible membrane overlying the frame structure. The frame structure is collapsible upon advancement of the device into the air passageway, expandable into a rigid structure upon deployment in the air passageway whereby the flexible membrane obstructs inhaled air flow into a lung portion communicating with the air passageway, and re-collapsible upon removal from the air passageway.
The invention still further provides an air passageway obstruction device comprising frame means for forming a support structure, and flexible membrane means overlying the support structure. The frame means is expandable to an expanded state within an air passageway to position the membrane means for obstructing air flow within the air passageway and is collapsible for removal of the device from the air passageway.
The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like referenced numerals identify identical elements, and wherein:
Referring now to
The respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, the bronchial branches 34, 36, 38, 40, and 42 and sub-branches 44, 46, 48, and 50. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60. Each bronchial branch and sub-branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof. As used herein, the term “air passageway” is meant to denote either a bronchial branch or sub-branch which communicates with a corresponding individual lung lobe or lung lobe portion to provide inhaled air thereto or conduct exhaled air therefrom.
Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
In contrast to the healthy respiratory system of
In accordance with this embodiment of the present invention, COPD treatment or evaluation is initiated by feeding a conduit or catheter 70 down the trachea 28, into a mainstream bronchus such as the right mainstem bronchus 32, and into an air passageway such as the bronchial branch 42 or the bronchial sub-branch 50. An air passageway obstruction device embodying the present invention is then advanced down an internal lumen 71 of the catheter 70 for deployment in the air passageway. Once deployed, the obstruction device precludes inhaled air from entering the lung portion to be collapsed. In accordance with the present invention, it is preferable that the obstruction device take the form of a one-way valve. In addition to precluding inhaled air from entering the lung portion, the device further allows air within the lung portion to be exhaled. This results in more rapid collapse of the lung portion. However, obstruction devices which preclude both inhaled and exhaled air flow are contemplated as falling within the scope of the invention.
The catheter 70 is preferably formed of flexible material such as polyethylene. Also, the catheter 70 is preferably preformed with a bend 72 to assist the feeding of the catheter from the right mainstem bronchus 32 into the bronchial branch 42.
Each of the frame supports has a shape to define a generally cylindrical center portion 94 and a pair of oppositely extending inwardly arcuate conical end portions 96 and 98. The frame structure further includes a plurality of fixation members 100, 102, and 104 which extend distally from the proximal end 82. The fixation members have the generally conical shape and terminate in fixation projections or anchors 106, 108, and 110 which extend radially outwardly.
Overlying and partially enclosing the frame structure 86 is a flexible membrane 112. The flexible membrane extends over the generally cylindrical and conical portions 94 and 98 defined by the frame structure. Hence, the flexible membrane is opened in the proximal direction.
The flexible membrane may be formed of silicone or polyurethane, for example. It may be secured to the frame structure in a manner known in the art such as by crimping, riveting, or adhesion.
The frame structure 86 and the device 80 are illustrated in
When the device 80 is deployed, the frame structure 86 and flexible membrane 112 form an obstructing structure or one-way valve.
As shown in
The device 80 is shown in
The device 130 is of similar configuration to the device 80 previously described. Here however, the fixation members 136 and 138 are extensions of the frame supports 132 and 134, respectively. To that end, it will be noted in
When the device is to be removed, the frame structure of the device 130 is held stationary by a retractor within the catheter 70 and the catheter is advanced distally. When the catheter 70 engages the frame supports 132 and 134, the frame supports are deflected inwardly from their dashed line positions to their solid line positions. This also causes the fixation members 136 and 138 to be deflected inwardly from their dashed line positions to their solid line positions in the direction of arrows 154. These actions disengage the device 130 from the inner wall of the air passageway 42. Now, the retractor may pull the device into the internal lumen 71 of the catheter 70 for removal of the device 130 from the air passageway 42.
Since each of the frame supports are identical, only frame support 164 will be described herein. As will be noted, the support 164 includes a bend point 174 with a relatively long section 176 extending distally from the bend point 174 and a relatively short section 178 extending proximally from the bend point 174. The short section 178 includes a fixation projection or anchor 180 extending slightly distally from the bend point 174.
The relatively long sections of the frame supports are covered with a flexible membrane 186 as shown in
While particular embodiments of the present invention have been shown and described, modifications may be made, and it is therefore intended in the appended claims to cover all such changes and modifications which fall within the true spirit and scope of the invention.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2832078 *||Oct 17, 1956||Apr 29, 1958||Battelle Memorial Institute||Heart valve|
|US2981254 *||Nov 12, 1957||Apr 25, 1961||Vanderbilt Edwin G||Apparatus for the gas deflation of an animal's stomach|
|US3320972 *||Apr 16, 1964||May 23, 1967||High Roy F||Prosthetic tricuspid valve and method of and device for fabricating same|
|US3445916 *||Apr 19, 1967||May 27, 1969||Schulte Rudolf R||Method for making an anatomical check valve|
|US3657744 *||May 8, 1970||Apr 25, 1972||Univ Minnesota||Method for fixing prosthetic implants in a living body|
|US3671979 *||Sep 23, 1969||Jun 27, 1972||Univ Utah||Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve|
|US3788327 *||Mar 30, 1971||Jan 29, 1974||Donowitz H||Surgical implant device|
|US3874388 *||Feb 12, 1973||Apr 1, 1975||Ochsner Med Found Alton||Shunt defect closure system|
|US4014318 *||May 22, 1975||Mar 29, 1977||Dockum James M||Circulatory assist device and system|
|US4084268 *||Apr 22, 1976||Apr 18, 1978||Shiley Laboratories, Incorporated||Prosthetic tissue heart valve|
|US4086665 *||Dec 16, 1976||May 2, 1978||Thermo Electron Corporation||Artificial blood conduit|
|US4250873 *||Apr 17, 1978||Feb 17, 1981||Richard Wolf Gmbh||Endoscopes|
|US4727873 *||Nov 26, 1986||Mar 1, 1988||Mobin Uddin Kazi||Embolus trap|
|US4732152 *||Dec 5, 1985||Mar 22, 1988||Medinvent S.A.||Device for implantation and a method of implantation in a vessel using such device|
|US4795449 *||Aug 4, 1986||Jan 3, 1989||Hollister Incorporated||Female urinary incontinence device|
|US4808183 *||Jun 3, 1980||Feb 28, 1989||University Of Iowa Research Foundation||Voice button prosthesis and method for installing same|
|US4819664 *||Feb 17, 1988||Apr 11, 1989||Stefano Nazari||Device for selective bronchial intubation and separate lung ventilation, particularly during anesthesia, intensive therapy and reanimation|
|US4830003 *||Jun 17, 1988||May 16, 1989||Wolff Rodney G||Compressive stent and delivery system|
|US4832680 *||Jul 3, 1986||May 23, 1989||C.R. Bard, Inc.||Apparatus for hypodermically implanting a genitourinary prosthesis|
|US4934999 *||Jul 28, 1988||Jun 19, 1990||Paul Bader||Closure for a male urethra|
|US5116360 *||Dec 27, 1990||May 26, 1992||Corvita Corporation||Mesh composite graft|
|US5116564 *||Oct 10, 1989||May 26, 1992||Josef Jansen||Method of producing a closing member having flexible closing elements, especially a heart valve|
|US5283063 *||Jan 31, 1992||Feb 1, 1994||Eagle Vision||Punctum plug method and apparatus|
|US5304199 *||Jan 4, 1993||Apr 19, 1994||Gene E. Myers Enterprises, Inc.||Apparatus for arterial total occlusion plaque separation|
|US5306234 *||Mar 23, 1993||Apr 26, 1994||Johnson W Dudley||Method for closing an atrial appendage|
|US5314473 *||Jan 5, 1993||May 24, 1994||Godin Norman J||Prosthesis for preventing gastric reflux into the esophagus|
|US5382261 *||Sep 1, 1992||Jan 17, 1995||Expandable Grafts Partnership||Method and apparatus for occluding vessels|
|US5392775 *||Mar 22, 1994||Feb 28, 1995||Adkins, Jr.; Claude N.||Duckbill valve for a tracheostomy tube that permits speech|
|US5398844 *||Jan 31, 1994||Mar 21, 1995||Boston Scientific Corporation||Multiple ligating band dispenser|
|US5409019 *||Nov 3, 1993||Apr 25, 1995||Wilk; Peter J.||Coronary artery by-pass method|
|US5411507 *||Jan 5, 1994||May 2, 1995||Richard Wolf Gmbh||Instrument for implanting and extracting stents|
|US5411552 *||Jun 14, 1994||May 2, 1995||Andersen; Henning R.||Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis|
|US5413599 *||Dec 13, 1993||May 9, 1995||Nippon Zeon Co., Ltd.||Medical valve apparatus|
|US5417226 *||Jun 9, 1994||May 23, 1995||Juma; Saad||Female anti-incontinence device|
|US5484444 *||Oct 14, 1993||Jan 16, 1996||Schneider (Europe) A.G.||Device for the implantation of self-expanding endoprostheses|
|US5486154 *||Jun 8, 1993||Jan 23, 1996||Kelleher; Brian S.||Endoscope|
|US5499995 *||May 25, 1994||Mar 19, 1996||Teirstein; Paul S.||Body passageway closure apparatus and method of use|
|US5500014 *||May 9, 1994||Mar 19, 1996||Baxter International Inc.||Biological valvular prothesis|
|US5507754 *||Aug 20, 1993||Apr 16, 1996||United States Surgical Corporation||Apparatus and method for applying and adjusting an anchoring device|
|US5507797 *||Aug 15, 1994||Apr 16, 1996||Sumitomo Bakelite Company Limited||Slidable kit for endoscopic ligation|
|US5509900 *||Oct 15, 1993||Apr 23, 1996||Kirkman; Thomas R.||Apparatus and method for retaining a catheter in a blood vessel in a fixed position|
|US5603698 *||Aug 23, 1995||Feb 18, 1997||Boston Scientific Corporation||Prosthesis delivery system|
|US5725519 *||Sep 30, 1996||Mar 10, 1998||Medtronic Instent Israel Ltd.||Stent loading device for a balloon catheter|
|US5752965 *||Oct 21, 1996||May 19, 1998||Bio-Vascular, Inc.||Apparatus and method for producing a reinforced surgical fastener suture line|
|US5755770 *||Jan 31, 1995||May 26, 1998||Boston Scientific Corporatiion||Endovascular aortic graft|
|US5855587 *||Aug 22, 1996||Jan 5, 1999||Chon-Ik Hyon||Hole forming device for pierced earrings|
|US5855597 *||May 7, 1997||Jan 5, 1999||Iowa-India Investments Co. Limited||Stent valve and stent graft for percutaneous surgery|
|US5855601 *||Jun 21, 1996||Jan 5, 1999||The Trustees Of Columbia University In The City Of New York||Artificial heart valve and method and device for implanting the same|
|US5876445 *||Nov 26, 1996||Mar 2, 1999||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|US6009614 *||Apr 21, 1998||Jan 4, 2000||Advanced Cardiovascular Systems, Inc.||Stent crimping tool and method of use|
|US6010525 *||Aug 1, 1997||Jan 4, 2000||Peter M. Bonutti||Method and apparatus for securing a suture|
|US6020380 *||Nov 25, 1998||Feb 1, 2000||Tap Holdings Inc.||Method of treating chronic obstructive pulmonary disease|
|US6027525 *||May 23, 1997||Feb 22, 2000||Samsung Electronics., Ltd.||Flexible self-expandable stent and method for making the same|
|US6045560 *||Jun 17, 1996||Apr 4, 2000||United States Surgical Corporation||Surgical stapling apparatus with biocompatible surgical fabric|
|US6051022 *||Dec 30, 1998||Apr 18, 2000||St. Jude Medical, Inc.||Bileaflet valve having non-parallel pivot axes|
|US6068635 *||Jun 4, 1998||May 30, 2000||Schneider (Usa) Inc||Device for introducing an endoprosthesis into a catheter shaft|
|US6068638 *||Oct 27, 1998||May 30, 2000||Transvascular, Inc.||Device, system and method for interstitial transvascular intervention|
|US6168614 *||Feb 20, 1998||Jan 2, 2001||Heartport, Inc.||Valve prosthesis for implantation in the body|
|US6174323 *||Jun 5, 1998||Jan 16, 2001||Broncus Technologies, Inc.||Method and assembly for lung volume reduction|
|US6183520 *||Nov 10, 1998||Feb 6, 2001||Galt Laboratories, Inc.||Method of maintaining urinary continence|
|US6200333 *||Dec 31, 1998||Mar 13, 2001||Broncus Technologies, Inc.||Bronchial stenter|
|US6203551 *||Oct 4, 1999||Mar 20, 2001||Advanced Cardiovascular Systems, Inc.||Chamber for applying therapeutic substances to an implant device|
|US6206918 *||May 12, 1999||Mar 27, 2001||Sulzer Carbomedics Inc.||Heart valve prosthesis having a pivot design for improving flow characteristics|
|US6231589 *||Mar 22, 1999||May 15, 2001||Microvena Corporation||Body vessel filter|
|US6234996 *||Jun 23, 1999||May 22, 2001||Percusurge, Inc.||Integrated inflation/deflation device and method|
|US6238334 *||Nov 3, 1998||May 29, 2001||Cardio Technologies, Inc.||Method and apparatus for assisting a heart to pump blood|
|US6355014 *||Mar 13, 1998||Mar 12, 2002||Medtronic Percusurge, Inc.||Low profile catheter valve|
|US6503272 *||Mar 21, 2001||Jan 7, 2003||Cordis Corporation||Stent-based venous valves|
|US6510848 *||Apr 21, 1999||Jan 28, 2003||Mallinckrodt, Inc.||Disposable active humidifier for the mechanical ventilation of a patient|
|US6514290 *||Oct 6, 2000||Feb 4, 2003||Broncus Technologies, Inc.||Lung elastic recoil restoring or tissue compressing device and method|
|US6527761 *||Oct 27, 2000||Mar 4, 2003||Pulmonx, Inc.||Methods and devices for obstructing and aspirating lung tissue segments|
|US6540782 *||Feb 1, 2001||Apr 1, 2003||Robert V. Snyders||Artificial heart valve|
|US6544291 *||Mar 26, 2001||Apr 8, 2003||Thomas V. Taylor||Sutureless gastroesophageal anti-reflux valve prosthesis and tool for peroral implantation thereof|
|US6558429 *||Mar 26, 2001||May 6, 2003||Reflux Corporation||Perorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof|
|US6568387 *||Jul 18, 2001||May 27, 2003||University Of Florida||Method for treating chronic obstructive pulmonary disorder|
|US6569166 *||Jul 24, 2001||May 27, 2003||Spiration, Inc.||Method for expanding the thorax|
|US6679264 *||Mar 4, 2000||Jan 20, 2004||Emphasys Medical, Inc.||Methods and devices for use in performing pulmonary procedures|
|US6682250 *||Nov 7, 2001||Jan 27, 2004||Lockheed Martin Corporation||Position-adjustable fastening apparatus and method|
|US6694979 *||Mar 2, 2001||Feb 24, 2004||Emphasys Medical, Inc.||Methods and devices for use in performing pulmonary procedures|
|US6709401 *||Jul 2, 2001||Mar 23, 2004||Pulmonx||Methods, systems, and kits for lung volume reduction|
|US6712812 *||Sep 4, 2001||Mar 30, 2004||Broncus Technologies, Inc.||Devices for creating collateral channels|
|US6722360 *||Jun 14, 2001||Apr 20, 2004||Rajiv Doshi||Methods and devices for improving breathing in patients with pulmonary disease|
|US6860847 *||Jul 10, 2001||Mar 1, 2005||Spiration, Inc.||Constriction device viewable under X ray fluoroscopy|
|US6989027 *||Apr 29, 2004||Jan 24, 2006||Medtronic Vascular Inc.||Percutaneously delivered temporary valve assembly|
|US7011094 *||Jul 25, 2003||Mar 14, 2006||Emphasys Medical, Inc.||Bronchial flow control devices and methods of use|
|US20020007831 *||Jul 18, 2001||Jan 24, 2002||Davenport Paul W.||Method for treating chronic obstructive pulmonary disorder|
|US20020052626 *||Apr 20, 2001||May 2, 2002||Paul Gilson||Embolic protection system|
|US20020062120 *||Dec 13, 2001||May 23, 2002||Pulmonx||Methods, systems, and kits for lung volume reduction|
|US20030018327 *||Jul 18, 2002||Jan 23, 2003||Csaba Truckai||Systems and techniques for lung volume reduction|
|US20030018344 *||Jul 19, 2002||Jan 23, 2003||Olympus Optical Co., Ltd.||Medical device and method of embolizing bronchus or bronchiole|
|US20030024527 *||Aug 3, 2001||Feb 6, 2003||Integrated Vascular Systems, Inc.||Lung assist apparatus and methods for use|
|US20030050648 *||Sep 11, 2001||Mar 13, 2003||Spiration, Inc.||Removable lung reduction devices, systems, and methods|
|US20030051733 *||Sep 10, 2002||Mar 20, 2003||Pulmonx||Method and apparatus for endobronchial diagnosis|
|US20030055331 *||Sep 11, 2002||Mar 20, 2003||Pulmonx||Methods of endobronchial diagnosis using imaging|
|US20030070682 *||Oct 10, 2002||Apr 17, 2003||Wilson Peter M.||Bronchial flow control devices and methods of use|
|US20030083671 *||Oct 25, 2001||May 1, 2003||Spiration, Inc.||Bronchial obstruction device deployment system and method|
|US20040039250 *||May 28, 2003||Feb 26, 2004||David Tholfsen||Guidewire delivery of implantable bronchial isolation devices in accordance with lung treatment|
|US20050033310 *||May 17, 2004||Feb 10, 2005||Alferness Clifton A.||Intra-bronchial valve devices|
|US20050033344 *||Sep 3, 2004||Feb 10, 2005||Dillard David H.||One-way valve devices for anchored implantation in a lung|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7451765||Jul 1, 2005||Nov 18, 2008||Mark Adler||Intra-bronchial apparatus for aspiration and insufflation of lung regions distal to placement or cross communication and deployment and placement system therefor|
|US7682332||Jun 30, 2004||Mar 23, 2010||Portaero, Inc.||Methods to accelerate wound healing in thoracic anastomosis applications|
|US7686013||Feb 12, 2008||Mar 30, 2010||Portaero, Inc.||Variable resistance pulmonary ventilation bypass valve|
|US7691151||Oct 24, 2006||Apr 6, 2010||Spiration, Inc.||Articulable Anchor|
|US7726305||Feb 12, 2008||Jun 1, 2010||Portaero, Inc.||Variable resistance pulmonary ventilation bypass valve|
|US7753052||Feb 6, 2008||Jul 13, 2010||Portaero, Inc.||Intra-thoracic collateral ventilation bypass system|
|US7757692||Apr 22, 2009||Jul 20, 2010||Spiration, Inc.||Removable lung reduction devices, systems, and methods|
|US7771472||Nov 18, 2005||Aug 10, 2010||Pulmonx Corporation||Bronchial flow control devices and methods of use|
|US7789083||Jan 31, 2008||Sep 7, 2010||Portaero, Inc.||Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease|
|US7811274||Apr 27, 2004||Oct 12, 2010||Portaero, Inc.||Method for treating chronic obstructive pulmonary disease|
|US7824366||Dec 10, 2004||Nov 2, 2010||Portaero, Inc.||Collateral ventilation device with chest tube/evacuation features and method|
|US7828789||Apr 7, 2008||Nov 9, 2010||Portaero, Inc.||Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis|
|US7842061||Dec 23, 2003||Nov 30, 2010||Spiration, Inc.||Methods of achieving lung volume reduction with removable anchored devices|
|US7875048||Sep 3, 2004||Jan 25, 2011||Spiration, Inc.||One-way valve devices for anchored implantation in a lung|
|US7896008||Aug 6, 2007||Mar 1, 2011||Portaero, Inc.||Lung reduction system|
|US7909803||Feb 18, 2009||Mar 22, 2011||Portaero, Inc.||Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease|
|US7927324||Feb 18, 2009||Apr 19, 2011||Portaero, Inc.||Aspirator and method for pneumostoma management|
|US7931641||Feb 21, 2008||Apr 26, 2011||Portaero, Inc.||Visceral pleura ring connector|
|US7942931||Aug 15, 2005||May 17, 2011||Spiration, Inc.||Device and method for intra-bronchial provision of a therapeutic agent|
|US8454708||Jun 4, 2013||Spiration, Inc.||Articulable anchor|
|US8647392||Apr 26, 2012||Feb 11, 2014||Spiration, Inc.||Articulable anchor|
|US20040143282 *||Dec 23, 2003||Jul 22, 2004||Dillard David H.||Methods of achieving lung volume reduction with removable anchored devices|
|US20040210248 *||Mar 12, 2003||Oct 21, 2004||Spiration, Inc.||Apparatus, method and assembly for delivery of intra-bronchial devices|
|US20040211412 *||May 17, 2004||Oct 28, 2004||Alferness Clifton A.||Removable lung reduction devices, systems, and method|
|US20040225254 *||Apr 27, 2004||Nov 11, 2004||Don Tanaka||Localized pleurodesis chemical delivery|
|US20040237966 *||May 20, 2004||Dec 2, 2004||Don Tanaka||Methods and devices to assist pulmonary decompression|
|US20040244803 *||May 24, 2004||Dec 9, 2004||Don Tanaka||Intra-thoracic collateral ventilation bypass system|
|US20050025816 *||Jun 30, 2004||Feb 3, 2005||Don Tanaka||Methods and devices to accelerate wound healing in thoracic anastomosis applications|
|US20050033310 *||May 17, 2004||Feb 10, 2005||Alferness Clifton A.||Intra-bronchial valve devices|
|US20050033344 *||Sep 3, 2004||Feb 10, 2005||Dillard David H.||One-way valve devices for anchored implantation in a lung|
|US20100070050 *||Mar 18, 2010||Pneumrx, Inc.||Enhanced Efficacy Lung Volume Reduction Devices, Methods, and Systems|
|International Classification||A61F11/00, A61D1/12, A61M16/00, A61M16/04, A61B, A61M15/00, A61B17/00, A61B17/12, A61B17/24|
|Cooperative Classification||A61B17/12172, A61B2017/1205, A61B17/12022, A61M16/0404, A61B17/12104, A61B17/12036|
|European Classification||A61B17/12P7W1, A61B17/12P5A, A61B17/12P1P, A61B17/12P|
|Sep 20, 2004||AS||Assignment|
Owner name: SPIRATION, INC., WASHINGTON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ALFERNESS, CLIFTON A.;LIN, RICHARD Y.;JAEGER, WILFRED E.;REEL/FRAME:015152/0244;SIGNING DATES FROM 20040914 TO 20040917